APPLICATIONS PUBLISHED 14 JANUARY 2004
Published: 1-Jun-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Large, porous particles produced controlling humidity during a spray drying process
Advanced Inhalation Research; The Penn State Research Foundation 1379219*
Inhalation capsules
Boehringer Ingelheim Pharma 1379220*
Pharmaceutical product with reticulated crystalline microstructure
Vectura 1379221*
Orodispersible effervescent tablets
Ethypharm 1379222*
Dental formulation
CS Bioscience 1379223*
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
Synergy Pharmaceuticals 1379224*
Novel medicament compsns based on anticholinergic agents and endothelin antagonists
Boehringer Ingelheim Pharma 1379225*
Animal model for evaluating analgesics
Zagros Pharma 1379226*
Microemulsions as precursors to solid nanoparticles
University of Kentucky Research Foundation 1379227*
(Z)-styrylbenzylsulphones and pharmaceutical uses thereof
Temple University of the Commonwealth System of Higher Education 1379228*
A jasmonate pharmaceutical compsn for treatment of cancer
Ramot University, Authority for Applied Research and Development 1379229*
Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
University of Pittsburgh of the Commonwealth System of Higher Education 1379230*
Pharmacologically active strong acid solutions
Cytorex Biosciences 1379231*
N-acetylcysteine compsns and methods for the treatment and prevention of drug toxicity
Bioadvantex Pharma 1379232*
Use of a substantially cell membrane impermeable compound for treating arthritis
Unisearch 1379233*
Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of IL-1 and TNF
Novartis 1379234*
Compounds and methods for enhancing paracellular permeability across epithelial and endothelial barriers
University of North Carolina 1379235*
Treatment of tics, tremors and related disorders
The Johns Hopkins University 1379236*
Pyrrolidine sulphonamides
SmithKline Beecham 1379237*
Favourable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
Abbott Laboratories 1379238*
N-(2-arylethyl) benzylamines as antagonists of the 5-HT6 receptor
Eli Lilly 1379239*
Compounds and methods
SmithKline Beecham 1379240*
Compounds and methods
SmithKline Beecham 1379241*
Method for treatment of cancer and compsns for use therein
Unisearch 1379242*
Methods for treating metabolic diseases using malonyl-CoA decarboxylase inhibitors
Chugai Saiyaku KK 1379243*
1,4,5,6-tetrahydropyrazolo-3,4-c]-pyridine-7-ones as factor XA inhibitors
Bristol-Myers Squibb 1379244*
1,4,5,6-tetrahydropyrazolo-3,4-c]-pyridine-7-ones as factor XA inhibitors
Bristol-Myers Squibb 1379245*
Nociceptin analogues
Euro-Celtique 1379246*
Agent for topical ophthalmic treatment of ocular inflammatory diseases
Sucampo 1379247*
Tricyclic compounds useful as HIV reverse transcriptase inhibitors
Bristol-Myers Squibb 1379248*
Fused cyclic succinimide compounds and analogues thereof, modulators of nuclear hormone receptor function
Bristol-Myers Squibb 1379249*
A method of treating cancer
Merck 1379250*
Inhibitors of AKT activity
Merck 1379251*
Nociceptin analogues
Euro-Celtique 1379252*
Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, The National Institute of Health 1379253*
Use of bile acid or bile salt fatty acid conjugates
Gaimed International 1379254*
Substituted tetracycline compounds as antifungal agents
Paratek Pharmaceuticals 1379255*
Method for the prevention of tissue elastic fibre injury
The Trustees of Columbia University in the City of New York 1379256*
Prodrugs of anticancer agents employing substituted aromatic acids
Enzon 1379257*
Low salt forms of polyallylamine
Geltex Pharmaceuticals 1379258*
Methods of treating syndrome X with aliphatic polyamines
Genzyme 1379259*
Methods for treating the inflammatory component of a brain disorder
Vasogen Ireland 1379260*
Methods for increasing serotonin levels in a person by administration of a compsn incorporating (-)-hydroxyxitric acid, and related compsns thereof
Interhealth Nutraceuticals 1379261*
Method of preparing an extract of Ginkgo biloba leaves highly enriched in active principles
Societe de Conseils de Recherches et d'Applications Scientifiques 1379262*
Mutated molecules for use in immune suppression
Isis Innovation 1379263*
Human secreted proteins
Human Genome Sciences 1379264*
Short bioactive peptides and methods for their use
Helix Biomedix 1379265*
Modified annexin proteins and methods for preventing thrombosis
SurroMed 1379266*
The use of the protein UK114 for the treatment and prevention of chronic active hepatitis
Zetesis 1379267*
Chrondogenic potential of human bone marrow-derived CD105?+ cells by BMP
Genetics Institute 1379268*
Adenosine A2A receptor antagonists combined with neurotrophic activity compounds in the treatment of Parkinson's disease
Neurosearch 1379269*
Method of inducing immune tolerance
Unisearch 1379270*
Method for treating von Willebrand's disease
ZymoGenetics 1379271*
Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
Chiron 1379272*
Nucleic acid adjuvants
Powderject Vaccines 1379273*
Methods for inhibition of angiogenesis, tumour growth and metastasis by fully human anti-IL8 and anti-MUC18 in diverse types of tumours
Board of Regents, the University of Texas System 1379274*
Chronic obstructive pulmonary disease-related immunoglobulin derived proteins, compsns, methods and uses
Centocor 1379275*
Combination methods of inhibiting tumour growth with a vascular endothelial growth factor receptor antagonist
Imclone Systems; Rockwell, Patricia; Goldstein, Neil 1379276*
Polyclonal populations of bispecific molecules and methods for production and uses thereof
Elusys Therapeutics 1379277*
Method of inducing proliferation of retinal stem cells
ZymoGenetics 1379278*
Orally deliverable pharmaceutical compsn comprising a drug of low water solubility (COX-2 inhibitor), a solvent, a fatty acid and an organic amine
Pharmacia Corp 1379279*
Immunogenic complex
Timmerman, Benedikt 1379280*
A helper dependent adenoviral vector system and methods for using the same
The Board of Trustees of the Leland Stanford Junior University 1379281*
Methods and compsns for the treatment and/or diagnosis of neurological diseases and disorders
Ramot at Tel Aviv University 1379282*
Identification of target-specific folding sites in peptides and proteins
Palatin Technoligies 1379283*
